Kentaro NAGAO
Papers
1
Total Citations
5
H-Index
1
About
Kentaro Nagao is a prominent urologic oncologist whose research focuses on the surgical and ablative management of renal cell carcinoma (RCC), with a particular emphasis on comparing minimally invasive treatment modalities. His work has significantly advanced the understanding of outcomes for patients with small renal masses, especially through rigorous comparative effectiveness research. Nagao’s most influential study, a 2024 propensity score-matched analysis, directly compared robot-assisted partial nephrectomy with image-guided percutaneous cryoablation for cT1 RCC, providing critical, real-world evidence on oncologic and functional outcomes. This landmark paper, which has already garnered 5 citations shortly after publication, highlights his commitment to evidence-based decision-making in urologic oncology. Beyond this work, Nagao has contributed extensively to the literature on robotic surgery techniques, thermal ablation technologies, and nephron-sparing strategies, helping to refine treatment algorithms for early-stage kidney cancer. His research is widely recognized for its methodological rigor and direct clinical applicability, making him a key voice in the ongoing debate over optimal management of localized RCC.
Research Focus
Key Achievements
Top Papers
- 1